Cargando…
Trastuzumab immunogenicity development in patients’ sera and in laboratory animals
BACKGROUND: Immunogenicity is a major challenge in drug development and patient care. Clinicians and regulators are familiar with immunogenicity concerns of monoclonal antibody (mAb) therapeutics, growth factors and enzyme replacements. Although most small therapeutic molecules are unlikely to trigg...
Autores principales: | Kilany, Lobna Abdel Aziz, Gaber, Ayman Abdel Samie, Aboulwafa, Mohammad Mabrouk, Zedan, Hamdallah Hafez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893875/ https://www.ncbi.nlm.nih.gov/pubmed/33607941 http://dx.doi.org/10.1186/s12865-021-00405-z |
Ejemplares similares
-
Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cancer cells
por: Taha, Amna Mohamed, et al.
Publicado: (2022) -
New typhoid vaccine using sponge-like reduced protocol: development and evaluation
por: Bahy, Rehab, et al.
Publicado: (2023) -
Evaluation of MMR live attenuated vaccine oncolytic potential using Ehrlich ascites carcinoma in a murine model
por: Hassan, Sara T., et al.
Publicado: (2022) -
Aesthetic reconstruction of onco-surgical maxillary defects using free scapular flap with and without CAD/CAM customized osteotomy guide
por: Alwadeai, Mohamed Salah, et al.
Publicado: (2022) -
Characterization and Complete Sequence of Lactonase Enzyme from Bacillus weihenstephanensis Isolate P65 with Potential Activity against Acyl Homoserine Lactone Signal Molecules
por: Mohammed Sakr, Masarra, et al.
Publicado: (2013)